QS Investors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $11.6M | Sell |
103,140
-189,626
| -65% | -$21.4M | 0.14% | 108 |
|
|
2021
Q1 | $31.7M | Sell |
292,766
-52,549
| -15% | -$5.62M | 0.37% | 35 |
|
|
2020
Q4 | $37M | Sell |
345,315
-18,232
| -5% | -$1.75M | 0.44% | 26 |
|
|
2020
Q3 | $31.8M | Sell |
363,547
-69,525
| -16% | -$6.55M | 0.43% | 29 |
|
|
2020
Q2 | $42.5M | Buy |
433,072
+189,273
| +78% | +$16.7M | 0.59% | 20 |
|
|
2020
Q1 | $18.6M | Sell |
243,799
-38,266
| -14% | -$3.26M | 0.3% | 58 |
|
|
2019
Q4 | $25.3M | Buy |
282,065
+114,336
| +68% | +$9.49M | 0.25% | 55 |
|
|
2019
Q3 | $12.7M | Sell |
167,729
-28,594
| -15% | -$1.96M | 0.14% | 113 |
|
|
2019
Q2 | $14.3M | Buy |
196,323
+6,732
| +4% | +$529K | 0.15% | 90 |
|
|
2019
Q1 | $15.3M | Buy |
189,591
+1,817
| +1% | +$149K | 0.17% | 82 |
|
|
2018
Q4 | $17.3M | Sell |
187,774
-99,773
| -35% | -$8.77M | 0.22% | 63 |
|
|
2018
Q3 | $27.2M | Sell |
287,547
-8,700
| -3% | -$825K | 0.26% | 50 |
|
|
2018
Q2 | $27.4M | Sell |
296,247
-1,969
| -0.7% | -$192K | 0.27% | 50 |
|
|
2018
Q1 | $28.2M | Sell |
298,216
-9,644
| -3% | -$1.06M | 0.29% | 49 |
|
|
2017
Q4 | $29.8M | Sell |
307,860
-11,029
| -3% | -$1.04M | 0.28% | 48 |
|
|
2017
Q3 | $28.3M | Sell |
318,889
-10,428
| -3% | -$794K | 0.23% | 64 |
|
|
2017
Q2 | $23.9M | Buy |
329,317
+24,287
| +8% | +$1.63M | 0.2% | 72 |
|
|
2017
Q1 | $19.9M | Sell |
305,030
-107,187
| -26% | -$6.74M | 0.17% | 79 |
|
|
2016
Q4 | $25.8M | Buy |
412,217
+2,019
| +0.5% | +$123K | 0.21% | 77 |
|
|
2016
Q3 | $25.9M | Sell |
410,198
-32,105
| -7% | -$2.08M | 0.2% | 85 |
|
|
2016
Q2 | $27.4M | Sell |
442,303
-18,507
| -4% | -$1.13M | 0.23% | 79 |
|
|
2016
Q1 | $26.3M | Buy |
460,810
+2,967
| +0.6% | +$165K | 0.25% | 75 |
|
|
2015
Q4 | $27.1M | Sell |
457,843
-4,851
| -1% | -$279K | 0.26% | 75 |
|
|
2015
Q3 | $25.2M | Sell |
462,694
-138,028
| -23% | -$8.98M | 0.26% | 70 |
|
|
2015
Q2 | $40.4M | Buy |
600,722
+71,313
| +13% | +$4.66M | 0.5% | 36 |
|
|
2015
Q1 | $31M | Sell |
529,409
-261,408
| -33% | -$15.8M | 0.35% | 54 |
|
|
2014
Q4 | $51.8M | Buy |
790,817
+544,013
| +220% | +$34.3M | 0.6% | 24 |
|
|
2014
Q3 | $14.3M | Sell |
246,804
-134,600
| -35% | -$7.47M | 0.38% | 77 |
|
|
2014
Q2 | $21.5M | Buy |
381,404
+102,343
| +37% | +$5.37M | 0.58% | 42 |
|
|
2014
Q1 | $14.3M | Buy |
279,061
+216,400
| +345% | +$10.9M | 0.43% | 68 |
|
|
2013
Q4 | $3.31M | Sell |
62,661
-2,900
| -4% | -$143K | 0.13% | 155 |
|
|
2013
Q3 | $2.93M | Sell |
65,561
-5,239
| -7% | -$232K | 0.13% | 170 |
|
|
2013
Q2 | $2.98M | Buy |
+70,800
| New | +$3.1M | 0.1% | 239 |
|
Other funds holding ABBV
QS Investors's ABBV Position: Q2 2021 in Review
QS Investors reduced its AbbVie (ABBV) stake by 65% in Q2 2021, selling an estimated $21.4M and leaving 103,140 shares worth $11.6M. The position accounts for 0.14% of the portfolio, ranked #108.
QS Investors first reported a position in ABBV in Q2 2013 and has held it in 33 quarters since. The position peaked at $51.8M in Q4 2014. 2,676 funds tracked by Wall St. Rank hold ABBV as of Q2 2021.
- QS Investors held 103,140 shares of AbbVie worth $11.6M as of Q2 2021.
- QS Investors sold 189,626 AbbVie shares in Q2 2021, an estimated $21.4M.
- AbbVie made up 0.14% of QS Investors's portfolio in Q2 2021, its #108 holding.
- QS Investors first reported a position in AbbVie in Q2 2013 and has held it in 33 quarters since.
- QS Investors's AbbVie position peaked at $51.8M in Q4 2014.
- 2,676 funds tracked by Wall St. Rank held AbbVie as of Q2 2021.
Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.